G2X TAKE: WOSB Citizant has been awarded a 5-year, $42M contract by the Department of the Treasury's Internal Revenue Service to provide HSPD-12 SmartID credentialing and maintenance support services. There were no other bidders for the contract, which was awarded on the General Service Administration's Federal Supply Schedule. Take Bytes Citizant has listed capabilities in application development, DevSecOps automation, identity, credential and access management, testing automation, cybersecurity hygiene, data management, IT modernization, and PMO support and brings experience with biometrics, identity management, imaging, and credentialing content management, with in-depth HSPD-12, OMB 11-11, FIPS 201, and FICAM domain expertise. Source: Citizant Citizant’s IRS HSPD-12 team has specialists in 26 states and Puerto Rico. The company has supported the IRS HSPD-12 mission requirement since 2012. With Citizant’s support in FY2018, the IRS Identity Credential and Access Management (ICAM) group processed more than 30,000 biometric identity card renewals – part of cyclical renewal surges that occur every 12 years. More on that here. This is just the latest IRS win for Citizant and follows a $6 million, 5-year task order from the Internal Revenue Service to continue application maintenance and enhancement on the Branded Prescription Drug system, part of the IRS’s legislative mandate under the Affordable Care Act. Citizant has been maintaining and enhancing BPD – the first ACA application deployed to production by the IRS – since 2012. Read more here. Led by CEO and Founder Alba Alemán and Vice President, Civilian Programs Matt Gallagher, Citizant has been building out its team of late, promoting David Romola to Chief Operating Officer and adding Megan Mattingly as Capture Manager. Award ID: 2032H522F00235 Referenced IDV ID: 47QSWA18D008L
Single Award
Treasury IRS awards $42M HSPD-12 SmartID Credentialing Support Services contractBy Jenny Reed
G2X TAKE: WOSB Citizant has been awarded a 5-year, $42M contract by the Department oApril 20, 2022